<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7434</journal-id>
<journal-title><![CDATA[Revista Colombiana de Obstetricia y Ginecología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Colomb Obstet Ginecol]]></abbrev-journal-title>
<issn>0034-7434</issn>
<publisher>
<publisher-name><![CDATA[Federación Colombiana de Obstetricia y GinecologíaRevista Colombiana de Obstetricia y Ginecología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74342017000200120</article-id>
<article-id pub-id-type="doi">10.18597/rcog.762</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Variación del volumen plaquetario medio y el ancho de distribución de plaquetas como marcador clínico temprano de preeclampsia]]></article-title>
<article-title xml:lang="en"><![CDATA[Variations in mean platelet volume and platelet distribution width as an early clinical marker for pre-eclampsia]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Portilla]]></surname>
<given-names><![CDATA[Christian Cifuentes-De la]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chang-García]]></surname>
<given-names><![CDATA[Mariana Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Especialidades Espíritu Santo Facultad de Ciencias Médicas ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Especialidades Espíritu Santo  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>68</volume>
<numero>2</numero>
<fpage>120</fpage>
<lpage>127</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74342017000200120&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74342017000200120&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74342017000200120&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Evaluar la variación del volumen plaquetario medio (VPM) y el ancho de distribución de plaquetas (ADP) como un marcador clínico relacionado con el desarrollo de la preeclampsia.  Materiales y métodos:  Estudio correlacional, ensamblado en una cohorte prospectiva en una población de mujeres con gestación de feto único de entre 14 y 40 años, sin antecedentes o presencia de patologías sistémicas vasculares, que asistieron al menos a dos controles prenatales en las semanas 13 y 33 de gestación, y que ingresaron posteriormente por complicaciones de fin de embarazo, o para atención de parto en un hospital de referencia ubicado en Guayaquil, Ecuador. Muestreo no probabilístico por conveniencia. Variables medidas: sociodemográficas, clínicas y valores de VPM y ADP en unidades de femtolitros (fL). Se compara la variación del VPM y el ADP entre las semanas 13 y 33 en el grupo de gestantes con y sin preeclampsia por medio de la prueba de rangos con signo de Wilcoxon para muestras relacionadas, y se evalúa la exactitud de estas pruebas para el diagnóstico de preeclampsia.  Resultados:  Se evaluaron 84 gestantes. Se encontró una variación promedio de 0,9 fL (DE ± 0,3) para el volumen plaquetario medio, y de 1,7 fL (DE ± 0,28) del ancho de distribución de plaquetas en las pacientes que desarrollaron preeclamsia. Las mejores características diagnósticas se encontraron al tomar el valor mínimo de variación de la media de 0,6 fL y 1,4 fL para VPM y ADP respectivamente, con un área bajo la curva de 0,75, un odds ratio diagnóstico (ORD) de 12,4, una sensibilidad de 61 % y una especificidad de 88,7 % para el diagnóstico de preeclampsia.  Conclusiones:  La evaluación de la variación de VPM y ADP entre el primer y tercer trimestre de gestación podría ser un método útil para el diagnóstico de la preeclampsia, independientemente del valor medido en cada etapa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective:  To assess mean platelet volume (MPV) and platelet distribution width (PDW) variations as a clinical marker associated with the development of pre-eclampsia.  Materials and methods:  Correlational study assembled in a prospective cohort of women with a singleton pregnancy, with age ranging between 14 and 40 years of age and no history or presence of systemic vascular disease, who attended at least two prenatal appointments at 13 and 33 weeks of gestation and were later admitted to hospital due to complications at the end of pregnancy, or for delivery in a reference hospital located in Guayaquil, Ecuador. Non-probabilistic convenience sampling was used. Variables measured: social, demographic, clinical, and MPV and PDW in femtolitres (fL). MPV and PDW variations were compared between week 13 and week 33 and between the groups of patients with and without pre-eclampsia using the Wilcoxon signed-ranked test for related samples; the accuracy of these tests for the diagnosis of pre-eclampsia was assessed.  Results:  Overall, 84 pregnant women were assessed. A mean variation of 0.9 fL (SD ± 0.3) was found for mean platelet volume and of 1.7 fL (SD ± 0.28) for platelet distribution width in patients who developed pre-eclampsia. The best diagnostic features were found when using the minimum mean variation values of 0.6 fL and 1.4 fL for MPV and PDW, respectively, with an area under the curve of 0.75, a diagnostic odds ratio (DOR) of 12.4, and a sensitivity and specificity of 61% and 88.7%, respectively, for the diagnosis of pre-eclampsia.  Conclusions:  Assessment of MPV and PDW variation between the first and the third trimester of gestation could be a useful method for diagnosing pre-eclampsia, regardless of the value measured in each stage.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[diagnóstico]]></kwd>
<kwd lng="es"><![CDATA[preeclampsia]]></kwd>
<kwd lng="es"><![CDATA[signos y síntomas]]></kwd>
<kwd lng="es"><![CDATA[plaquetas]]></kwd>
<kwd lng="en"><![CDATA[Diagnosis]]></kwd>
<kwd lng="en"><![CDATA[pre-eclampsia]]></kwd>
<kwd lng="en"><![CDATA[signs and symptoms]]></kwd>
<kwd lng="en"><![CDATA[platelets]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>OMS</collab>
<source><![CDATA[Mortalidad Materna. Nota Descriptiva 348]]></source>
<year>2015</year>
<publisher-name><![CDATA[Organización Mundial de la Salud, Salud Materna, Centro de Prensa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murgueitio]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera-Escobar]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<source><![CDATA[Mortalidad materna evitable: meta del milenio como propósito nacional]]></source>
<year>2014</year>
<page-range>4-9</page-range><publisher-name><![CDATA[Monitor Estratégico]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[INEC]]></surname>
</name>
</person-group>
<source><![CDATA[Los índices de mortalidad materna]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Instituto Nacional de Estadísticas y Censos ]]></publisher-loc>
<publisher-name><![CDATA[Salud Materna]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Levend]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bloom]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hauth]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rouse]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Spong]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Williams Obstetrics]]></source>
<year>2010</year>
<edition>23rd ed</edition>
<publisher-name><![CDATA[McGraw-Hill Professional]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[ACOG]]></surname>
</name>
</person-group>
<source><![CDATA[Hypertension in Pregnancy]]></source>
<year>2014</year>
<publisher-loc><![CDATA[The American College of Obstetricians and Gynecologists ]]></publisher-loc>
<publisher-name><![CDATA[Task Force on Hypertension in Pregnancy]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Universidad Autónoma de Madrid</collab>
<source><![CDATA[Estructuras extraembrionarias y placenta]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Desarrollo Materno-Fetal]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>National Collaborating Centre for Women's and Children's Health</collab>
<source><![CDATA[Hypertension in Pregnancy: The management of hypertensive disorders during pregnancy]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Guideline ]]></publisher-loc>
<publisher-name><![CDATA[National Institute for Health and Clinical Excellence]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vijaya]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lekha]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Archana]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Geethamani]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of platelet counts and platelet indices and their significant role in pre-eclampsia and eclampsia]]></article-title>
<source><![CDATA[JEMDS]]></source>
<year>2014</year>
<volume>3</volume>
<page-range>3216-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crespo]]></surname>
<given-names><![CDATA[MEH]]></given-names>
</name>
</person-group>
<source><![CDATA[Aumento del volumen medio plaquetario como marcador para preeclampsia en el Hospital Vicente Corral Moscoso]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Cuenca ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Cuenca, Facultad de Ciencias Médicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AlSheeha]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Alaboudi]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Alghasham]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Iqbal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Adam]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet count and platelet indices in women with preeclampsia]]></article-title>
<source><![CDATA[Vasc Health Risk Manag]]></source>
<year>2016</year>
<volume>12</volume>
<page-range>477-80</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abass]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Abdalla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Omer]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Khalid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Elzein]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of platelets count and indices in pre-eclampsia compared to normal pregnancies]]></article-title>
<source><![CDATA[IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)]]></source>
<year>2016</year>
<volume>1</volume>
<page-range>5-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Noroña Calvachi]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preeclampsia la era de los marcadores bioquímicos]]></article-title>
<source><![CDATA[Rev Cient Cienc Méd]]></source>
<year>2014</year>
<volume>17</volume>
<page-range>32-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oviedo Ramírez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Caracterización histológica y expresión inmunohistoquímica de los marcadores p53 y p21 en el trofoblasto placentario en preeclampsia]]></source>
<year>2016</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de Murcia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navarro Echeverría]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Cribado precoz bioquímico y ecográfico de la preeclampsia y de otras complicaciones gestacionales]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Universidad Complutense de Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Facultad de Medicina, Departamento de Obstetricia y Ginecología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peñaloza-Valenzuela]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Molina-Maldonado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia- Flores]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torrico-Aponte]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Ardaya Guzmán]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ecografía Doppler como factor de predicción de preeclampsia y restricción del crecimiento fetal (RCIU)]]></article-title>
<source><![CDATA[Rev méd]]></source>
<year>2014</year>
<volume>19</volume>
<page-range>17-23</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ezzat]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Hasseeb]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gehad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamed]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of platelet indices and their significance in preeclampsia]]></article-title>
<source><![CDATA[Nature and Science]]></source>
<year>2014</year>
<volume>12</volume>
<page-range>147-53</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kanat-Pektas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yesildager]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Tuncer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Arioz]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Nadirgil-Koken]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Yilmazer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Could mean platelet volume in late first trimester of pregnancy predict intrauterine growth restriction and pre-eclampsia?]]></article-title>
<source><![CDATA[J Obstet Gynaecol Res]]></source>
<year>2014</year>
<volume>40</volume>
<page-range>1840-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[ang]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Kwon]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Sohn]]></surname>
<given-names><![CDATA[IS]]></given-names>
</name>
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Significance of the platelet distribution width as a severity marker for the development of preeclampsia]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>2014</year>
<volume>175</volume>
<page-range>107-11</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez Aguirre]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Alatorre Ricardo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cantú Rodríguez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Almaguer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome de Hellp, diagnóstico y tratamiento]]></article-title>
<source><![CDATA[Rev Hematolog Mex]]></source>
<year>2012</year>
<volume>13</volume>
<page-range>195-200</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dadhich]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Agrawal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Soni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Choudhary]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jain]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive value of platelet indices in development of preeclampsia]]></article-title>
<source><![CDATA[J SAFOG]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>17-21</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stepan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hund]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gencay]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Denk]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Dinkel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kaminski]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome]]></article-title>
<source><![CDATA[Hypertens pregnancy]]></source>
<year>2016</year>
<volume>35</volume>
<page-range>295-305</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Alpoim]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
<name>
<surname><![CDATA[Komatsuzaki]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Dusse]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preeclampsia: Are platelet count and indices useful for its prognostic?]]></article-title>
<source><![CDATA[Hematology]]></source>
<year>2013</year>
<volume>18</volume>
<page-range>360-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
